Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6549-6555

  Frenkel, Dan ^a   Huang, Zhihong ^a   Maron, Ruth ^a   Koldzic, Djordje N ^a   Hancock, Wayne W ^b   Moskowitz, Michael A ^a   Weiner, Howard L ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CYTOKINE; GLYCOPROTEIN; INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN [35-55]; NEUROPROTECTIVE AGENT; NITROGEN OXIDE; OVA PEPTIDE [325-345]; OVALBUMIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG; VACCINE;

ADOPTIVE TRANSFER; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BIOSYNTHESIS; BRAIN ISCHEMIA; CELL PROLIFERATION; CEREBRAL ARTERY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG MECHANISM; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; NUTRITIONAL DEFICIENCY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; STROKE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TIME SERIES ANALYSIS; TRANSPLANTATION; TREATMENT OUTCOME; VACCINATION;

EID: 0346366987     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6549     Document Type: Article

References (37)

1. Bogousslavsky, J., G. Van Melle, and F. Regli. 1988. The Lausanne Stroke Registry: analysis of 1, 000 consecutive patients with first stroke. Stroke 19:1083.
2. Hossmann, K. A. 1994. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36:557.
3. del Zoppo, G. J., K. J. Becker, and J. M. Hallenbeck. 2001. Inflammation after stroke: is it harmful? Arch. Neurol. 58:669.
4. Koroshetz, W. J., and M. A. Moskowitz. 1996. Emerging treatments for stroke in humans. Trends Pharmacol. Sci. 17:227.
5. Li, H. L., N. Kostulas, Y. M. Huang, B. G. Xiao, P. van der Meide, V. Kostulas, V. Giedraitas, and H. Link. 2001. IL-17 and IFN-γ mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. J. Neuroimmunol. 116:5.
6. Connolly, E. S., Jr., C. J. Winfree, C. J. Prestigiacomo, S. C. Kim, T. F. Choudhri, B. L. Hoh, Y. Naka, R. A. Solomon, and D. J. Pinsky. 1997. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ. Res. 81:304.
7. Zhang, R. L., M. Chopp, Y. Li, C. Zaloga, N. Jiang, M. L. Jones, M. Miyasaka, and P. A. Ward. 1994. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44:1747.
8. Hallenbeck, J. M. 2002. The many faces of tumor necrosis factor in stroke. Nat. Med. 8:1363.
9. Weiner, H. 2001. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182:207.
10. Groux, H. 2001. An overview of regulatory T cells. Microbes Infect. 3:883.
11. Weiner, H. L. 2001. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat. Immunol. 2:671.
12. Vila, N., J. Castillo, A. Davalos, A. Esteve, A. M. Planas, and A. Chamorro. 2003. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 34:671.
13. van Exel, E., J. Gussekloo, A. J. de Craen, A. Bootsma-van der Wiel, M. Frolich, and R. G. Westendorp. 2002. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 33:1135.
14. Krupinski, J., P. Kumar, S. Kumar, and J. Kaluza. 1996. Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke 27:852.
15. Becker, K. J., R. M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, K. C. Flanders, and J., M. Hallenbeck. 1997. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 94:10873.
16. Maron, R., N. S. Melican, and H. L. Weiner. 1999. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J. Autoimmun. 12:251.
17. Inobe, J., A. J. Slavin, Y. Komagata, Y. Chen, L. Liu, and H. L. Weiner. 1998. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28:2780.
18. Huang, Z., P. L. Huang, N. Panahian, T. Dalkara, M. C. Fishman, and M. A. Moskowitz. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883.
19. Huang, Z., P. L. Huang, J. Ma, W. Meng, C. Ayata, M. C. Fishman, and M. A. Moskowitz. 1996. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:981.
20. Endres, M., W. Z., Namura, S., Waeber, C., Moskowitz, M. A. 1997. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17:1143.
21. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
22. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:3299.
23. Hunter, A. J., K. B. Mackay, and D. C. Rogers. 1998. To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends Pharmacol. Sci. 19:59.
24. Lo, E. H., T. Dalkara, and M. A. Moskowitz. 2003. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4:399.
25. Faria, A. M. C., and H. L. Weiner. 1999. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73:153.
26. Emsley, H. C., and P. J. Tyrrell. 2002. Inflammation and infection in clinical stroke. J. Cereb. Blood Flow Metab. 22:1399.
27. Gregersen, R., T. Christensen, E. Lehrmann, N. H. Diemer, and B. Finsen. 2001. Focal cerebral ischemia induces increased myelin basic protein and growth-associated protein-43 gene transcription in peri-infarct areas in the rat brain. Exp. Brain Res. 138:384.
28. Maron, R., G. Sukhova, A. M. Faria, E. Hoffmann, F. Mach, P. Libby, and H. L. Weiner. 2002. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106:1708.
29. Bachis, A., A. M. Colangelo, S. Vicini, P. P. Doe, M. A. De Bernardi, G. Brooker, and I. Mocchetti. 2001. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 21:3104.
30. Schneider, A., A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger. 1999. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:554.
31. Becker, K., D. Kindrick, R. McCarron, J. Hallenbeck, and R. Winn. 2003. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34:1809.
32. Hall, G., C. G. Houghton, J. U. Rahbek, J. R. Lamb, and E. R. Jarman. 2003. Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. Vaccine 21:549.
33. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725.
34. Yoles, E., E. Hauben, O. Palgi, E. Agranov, A. Gothilf, A. Cohen, V. Kuchroo, I. R. Cohen, H. Weiner, and M. Schwartz. 2001. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21:3740.
35. Barouch, R., and M. Schwartz. 2002. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 16:1304.
36. Moalem, G., R. Leibowitz-Amit, E. Yoles, F. Mor, I. R. Cohen, and M. Schwartz. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:49.
37. Stoll, G., S. Jander, and M. Schroeter. 2002. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 513:87.